PDB Short entry for 2KW6 HEADER CELL CYCLE 31-MAR-10 2KW6 TITLE SOLUTION NMR STRUCTURE OF CYCLIN-DEPENDENT KINASE 2-ASSOCIATED PROTEIN TITLE 2 1 (CDK2-ASSOCIATED PROTEIN 1; ORAL CANCER SUPPRESSOR DELETED IN ORAL TITLE 3 CANCER 1, DOC-1) FROM H.SAPIENS, NORTHEAST STRUCTURAL GENOMICS TITLE 4 CONSORTIUM TARGET TARGET HR3057H COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 61-115; COMPND 5 SYNONYM: CDK2-ASSOCIATED PROTEIN 1, PUTATIVE ORAL CANCER SUPPRESSOR, COMPND 6 DELETED IN ORAL CANCER 1, DOC-1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2AP1, CDKAP1, DOC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET21 KEYWDS STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG), KEYWDS 2 PSI-2, PROTEIN STRUCTURE INITIATIVE, CANCER SUPPRESSOR, CELL CYCLE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.ERTEKIN,J.M.ARAMINI,P.ROSSI,A.B.LEE,M.JIANG,C.T.CICCOSANTI,R.XIAO, AUTHOR 2 G.V.T.SWAPNA,B.ROST,J.K.EVERETT,T.B.ACTON,J.H.PRESTEGARD, AUTHOR 3 G.T.MONTELIONE,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 4 14-JUN-23 2KW6 1 REMARK REVDAT 3 05-FEB-20 2KW6 1 REMARK SEQADV REVDAT 2 02-OCT-13 2KW6 1 JRNL VERSN REVDAT 1 26-MAY-10 2KW6 0 JRNL AUTH A.ERTEKIN,J.M.ARAMINI,P.ROSSI,P.G.LEONARD,H.JANJUA,R.XIAO, JRNL AUTH 2 M.MAGLAQUI,H.W.LEE,J.H.PRESTEGARD,G.T.MONTELIONE JRNL TITL HUMAN CYCLIN-DEPENDENT KINASE 2-ASSOCIATED PROTEIN 1 JRNL TITL 2 (CDK2AP1) IS DIMERIC IN ITS DISULFIDE-REDUCED STATE, WITH JRNL TITL 3 NATIVELY DISORDERED N-TERMINAL REGION. JRNL REF J.BIOL.CHEM. V. 287 16541 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22427660 JRNL DOI 10.1074/JBC.M112.343863 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, CYANA 3.0 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION OF THIS REMARK 3 SYMMETRIC HOMODIMER WAS PERFORMED ITERATIVELY USING CYANA3.0. REMARK 3 THE 20 STRUCTURES OUT OF 100 WITH LOWEST TARGET FUNCTION WERE REMARK 3 FURTHER REFINED BY RESTRAINED MOLECULAR DYNAMICS/ENERGY REMARK 3 MINIMIZATION IN EXPLICIT WATER USING CNS 1.1. RESIDUAL DIPOLAR REMARK 3 COUPLINGS WERE APPLIED AT ALL STAGES OF THE STRUCTURE REMARK 3 DETERMINATION. REMARK 4 REMARK 4 2KW6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000101648. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.9 MM [U-100% 13C; U-100% 15N] REMARK 210 HR3057H, 20 MM MES, 50 UM DSS, REMARK 210 200 MM NACL, 10 MM DTT, 5 MM REMARK 210 CACL2, 0.02 % SODIUM AZIDE, 95% REMARK 210 H2O/5% D2O; 0.68 MM [U-5% 13C; U- REMARK 210 100% 15N] HR3057H, 20 MM MES, 50 REMARK 210 UM DSS, 200 MM NACL, 10 MM DTT, REMARK 210 5 MM CACL2, 0.02 % SODIUM AZIDE, REMARK 210 95% H2O/5% D2O; 0.92 MM [U-100% REMARK 210 13C; U-100% 15N] + UNLABELED REMARK 210 HR3057H, 20 MM MES, 50 UM DSS, REMARK 210 200 MM NACL, 10 MM DTT, 5 MM REMARK 210 CACL2, 0.02 % SODIUM AZIDE, 95% REMARK 210 H2O/5% D2O; 0.68 MM [U-5% 13C; U- REMARK 210 100% 15N] + UNLABELED HR3057H, REMARK 210 20 MM MES, 50 UM DSS, 200 MM REMARK 210 NACL, 10 MM DTT, 5 MM CACL2, REMARK 210 0.02 % SODIUM AZIDE, 7 % REMARK 210 POLYACRYLAMIDE GEL, 95% H2O/5% REMARK 210 D2O; 0.9 MM [U-100% 13C; U-100% REMARK 210 15N] + UNLABELED HR3057H, 20 MM REMARK 210 MES, 50 UM DSS, 200 MM NACL, 10 REMARK 210 MM DTT, 5 MM CACL2, 0.02 % REMARK 210 SODIUM AZIDE, 4.2 % PEG, 95% H2O/ REMARK 210 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D SIMUTANEOUS 13C-AROMATIC,13C- REMARK 210 ALIPHATIC,15N EDITED 1H-1H NOESY; REMARK 210 3D HNCO; 3D HBHA(CO)NH; 2D 1H- REMARK 210 13C AROM NOESY; 3D HCCH-TOCSY; REMARK 210 3D HNCA; 3D HN(CO)CA; 3D HCCH- REMARK 210 COSY; 2D 1H-15N HETNOE; 3D REMARK 210 HNCACB; 3D HN(CA)CO; 3D CBCA(CO) REMARK 210 NH; 2D 1H-13C HSQC HIGH RES. (L/ REMARK 210 V METHYL STEREOSPECIFIC REMARK 210 ASSIGNMENT); 2D 1H-15N T1 REMARK 210 RELAXATION; 2D 1H-15N T2 REMARK 210 RELAXATION; X-FILTERED 13C NOESY; REMARK 210 2D 1H-15N TROSY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS, CYANA 3.0, AUTOSTRUCTURE REMARK 210 2.1, AUTOASSIGN 2.1, NMRPIPE, REMARK 210 TOPSPIN, VNMRJ, SPARKY 3, PINE REMARK 210 1.0, PSVS 1.4, TALOS + REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 54 91.47 -160.93 REMARK 500 1 HIS A 58 94.57 -67.57 REMARK 500 1 ALA A 113 -92.16 -101.83 REMARK 500 1 ARG A 114 72.28 163.17 REMARK 500 1 HIS B 258 109.01 -57.29 REMARK 500 1 HIS B 260 84.48 -63.74 REMARK 500 1 ASN B 312 -72.36 -74.50 REMARK 500 1 ARG B 314 -72.19 -78.12 REMARK 500 2 HIS A 53 61.31 -102.24 REMARK 500 2 HIS A 55 99.55 -54.06 REMARK 500 2 SER A 59 34.45 -86.75 REMARK 500 2 HIS A 60 -63.27 70.59 REMARK 500 2 ALA A 113 122.84 173.58 REMARK 500 2 HIS B 253 103.22 -59.56 REMARK 500 2 HIS B 258 104.56 -58.41 REMARK 500 2 ASN B 312 -76.22 -82.49 REMARK 500 3 ASN A 112 -83.96 -84.31 REMARK 500 3 HIS B 257 104.53 -56.50 REMARK 500 3 HIS B 258 86.66 -69.26 REMARK 500 4 HIS A 55 86.32 -68.63 REMARK 500 4 SER B 259 -143.78 -77.62 REMARK 500 4 HIS B 260 59.19 -115.88 REMARK 500 4 ASN B 312 -75.44 -78.15 REMARK 500 5 ALA A 113 44.77 -142.02 REMARK 500 5 HIS B 258 95.03 -65.80 REMARK 500 7 HIS A 54 97.80 -67.83 REMARK 500 7 HIS B 257 141.24 -174.70 REMARK 500 8 ASN B 312 -76.60 -71.41 REMARK 500 9 ARG A 114 -60.13 -101.91 REMARK 500 9 ASN B 312 -73.17 -100.69 REMARK 500 10 HIS A 60 91.61 -68.26 REMARK 500 11 HIS A 54 94.89 -66.84 REMARK 500 11 ARG A 114 62.35 179.89 REMARK 500 11 ASN B 312 -68.36 -95.57 REMARK 500 12 ASN A 112 -95.12 -79.87 REMARK 500 12 HIS B 257 86.32 -63.68 REMARK 500 12 ASN B 312 -74.02 -72.51 REMARK 500 13 ALA A 113 -158.43 -167.42 REMARK 500 13 ALA B 313 -157.79 -161.40 REMARK 500 14 HIS B 253 99.98 -64.38 REMARK 500 14 HIS B 256 -47.13 -136.57 REMARK 500 15 HIS A 57 96.19 -66.99 REMARK 500 15 HIS B 253 -62.11 -102.77 REMARK 500 16 HIS A 53 -48.64 -131.06 REMARK 500 16 ASN A 112 -80.30 -85.81 REMARK 500 16 ALA A 113 143.81 -38.68 REMARK 500 16 HIS B 253 -26.14 -160.61 REMARK 500 18 HIS B 258 81.06 -175.78 REMARK 500 18 HIS B 260 -100.92 -80.81 REMARK 500 18 ARG B 314 -71.71 -75.87 REMARK 500 REMARK 500 THIS ENTRY HAS 58 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16808 RELATED DB: BMRB REMARK 900 RELATED ID: HR3057H RELATED DB: TARGETDB DBREF 2KW6 A 61 115 UNP O14519 CDKA1_HUMAN 61 115 DBREF 2KW6 B 261 315 UNP O14519 CDKA1_HUMAN 61 115 SEQADV 2KW6 MET A 51 UNP O14519 EXPRESSION TAG SEQADV 2KW6 GLY A 52 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 53 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 54 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 55 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 56 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 57 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 58 UNP O14519 EXPRESSION TAG SEQADV 2KW6 SER A 59 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS A 60 UNP O14519 EXPRESSION TAG SEQADV 2KW6 MET B 251 UNP O14519 EXPRESSION TAG SEQADV 2KW6 GLY B 252 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 253 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 254 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 255 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 256 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 257 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 258 UNP O14519 EXPRESSION TAG SEQADV 2KW6 SER B 259 UNP O14519 EXPRESSION TAG SEQADV 2KW6 HIS B 260 UNP O14519 EXPRESSION TAG SEQRES 1 A 65 MET GLY HIS HIS HIS HIS HIS HIS SER HIS SER LYS TYR SEQRES 2 A 65 ALA GLU LEU LEU ALA ILE ILE GLU GLU LEU GLY LYS GLU SEQRES 3 A 65 ILE ARG PRO THR TYR ALA GLY SER LYS SER ALA MET GLU SEQRES 4 A 65 ARG LEU LYS ARG GLY ILE ILE HIS ALA ARG GLY LEU VAL SEQRES 5 A 65 ARG GLU CYS LEU ALA GLU THR GLU ARG ASN ALA ARG SER SEQRES 1 B 65 MET GLY HIS HIS HIS HIS HIS HIS SER HIS SER LYS TYR SEQRES 2 B 65 ALA GLU LEU LEU ALA ILE ILE GLU GLU LEU GLY LYS GLU SEQRES 3 B 65 ILE ARG PRO THR TYR ALA GLY SER LYS SER ALA MET GLU SEQRES 4 B 65 ARG LEU LYS ARG GLY ILE ILE HIS ALA ARG GLY LEU VAL SEQRES 5 B 65 ARG GLU CYS LEU ALA GLU THR GLU ARG ASN ALA ARG SER HELIX 1 1 SER A 61 GLY A 74 1 14 HELIX 2 2 GLU A 76 ALA A 82 1 7 HELIX 3 3 SER A 84 GLU A 110 1 27 HELIX 4 4 SER B 261 GLY B 283 1 23 HELIX 5 5 SER B 284 ALA B 313 1 30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000